Circio Holding ASA - Asset Resilience Ratio

Latest as of June 2025: 49.78%

Circio Holding ASA (CRNA) has an Asset Resilience Ratio of 49.78% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CRNA current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Nkr6.35 Million
≈ $667.78K USD Cash + Short-term Investments

Total Assets

Nkr12.75 Million
≈ $1.34 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Circio Holding ASA's Asset Resilience Ratio has changed over time. See Circio Holding ASA shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Circio Holding ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CRNA stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Nkr6.35 Million 49.78%
Short-term Investments Nkr0.00 0%
Total Liquid Assets Nkr6.35 Million 49.78%

Asset Resilience Insights

  • Very High Liquidity: Circio Holding ASA maintains exceptional liquid asset reserves at 49.78% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Circio Holding ASA Industry Peers by Asset Resilience Ratio

Compare Circio Holding ASA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 3.28%
Summit Therapeutics PLC
NASDAQ:SMMT
Biotechnology 0.00%
Argen-X
F:1AE
Biotechnology 25.67%
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229
Biotechnology 0.21%
R&G PharmaStudies Co. Ltd. A
SHE:301333
Biotechnology 35.96%
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
Biotechnology 79.48%
Innovita Biological Technology Co. Ltd. A
SHG:688253
Biotechnology 70.49%
Sunmax Biotechnology Co Ltd
TWO:4728
Biotechnology 10.53%

Annual Asset Resilience Ratio for Circio Holding ASA (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Circio Holding ASA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 81.73% Nkr17.84 Million
≈ $1.88 Million
Nkr21.83 Million
≈ $2.30 Million
+0.78pp
2023-12-31 80.95% Nkr20.81 Million
≈ $2.19 Million
Nkr25.71 Million
≈ $2.71 Million
+18.24pp
2022-12-31 62.71% Nkr62.97 Million
≈ $6.63 Million
Nkr100.41 Million
≈ $10.57 Million
+31.19pp
2021-12-31 31.52% Nkr178.18 Million
≈ $18.75 Million
Nkr565.27 Million
≈ $59.48 Million
+8.66pp
2020-12-31 22.86% Nkr119.07 Million
≈ $12.53 Million
Nkr520.74 Million
≈ $54.80 Million
--
pp = percentage points

About Circio Holding ASA

OL:CRNA Norway Biotechnology
Market Cap
$146.68 Million
Nkr1.39 Billion NOK
Market Cap Rank
#17739 Global
#150 in Norway
Share Price
Nkr9.41
Change (1 day)
-1.47%
52-Week Range
Nkr0.57 - Nkr14.40
All Time High
Nkr676.52
About

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a … Read more